Analyse the association between adverse events (AEs) and survival in patients treated with immune checkpoint inhibitors (ICIs)

被引：0
|
作者：
Cheng, C-Y. [1 ]
Su, P-J. [2 ]
Chang, K-C. [3 ]
Tsai, T-C. [3 ]
Chen, H-Y. [3 ]
Deng, S-T. [3 ]
Chang, W-C. [2 ]
机构：
[1] Linkou Chang Gung Mem Hosp, Chang Gung Med Fdn, Pharm, Taoyuan, Taiwan
[2] Chang Gung Mem Hosp, Med Oncol, Taoyuan, Taiwan
[3] Chang Gung Mem Hosp, Pharm, Taoyuan, Taiwan
来源：
ANNALS OF ONCOLOGY | 2019年 / 30卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
332P
引用
收藏
页数：2
相关论文
共 50 条
  • [41] Oral manifestations of immune-related adverse events in cancer patients treated with immune checkpoint inhibitors
    Klein, Brittany A.
    Alves, Fabio Abreu
    de Santana Rodrigues Velho, Julia
    Vacharotayangul, Piamkamon
    Hanna, Glenn J.
    LeBoeuf, Nicole R.
    Shazib, Muhammad Ali
    Villa, Alessandro
    Woo, Sook-Bin
    Sroussi, Herve
    Sonis, Stephen
    Treister, Nathaniel S.
    ORAL DISEASES, 2022, 28 (01) : 9 - 22
  • [42] Delayed immune-related adverse events in patients with advanced melanoma treated with immune checkpoint inhibitors
    Angeles, Arkhjamil
    Sonke, Eric
    Thao Phuong Nguyen
    Bahl, Gaurav
    Poon, Vincent Isaac
    Bernstein, Vanessa
    Weppler, Alison Margaret
    Savage, Kerry J.
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [43] Mechanisms Driving Immune-Related Adverse Events in Cancer Patients Treated with Immune Checkpoint Inhibitors
    Lee, David J.
    Lee, Howard J., Jr.
    Farmer, Jocelyn R.
    Reynolds, Kerry L.
    CURRENT CARDIOLOGY REPORTS, 2021, 23 (08)
  • [44] Mechanisms Driving Immune-Related Adverse Events in Cancer Patients Treated with Immune Checkpoint Inhibitors
    David J. Lee
    Howard J. Lee
    Jocelyn R. Farmer
    Kerry L. Reynolds
    Current Cardiology Reports, 2021, 23
  • [45] Impact of immune-related adverse events on survival in patients with metastastic urothelial carcinoma treated with immune-checkpoint inhibitors.
    Morales-Barrera, Rafael
    Suarez Rodriguez, Cristina
    Gonzalez, Macarena
    Ros, Javier
    Eugenia Semidey, Maria
    Hernandez, Ester Serra
    Mateo, Joaquin
    Saez, Carlos Fernandez
    Lozano, Fernando
    Mast, Richard
    Roche, Sarai
    Quintana, Angela
    Gutierrez Fernandez, Sara
    Serrano, Cesar
    Valverde, Claudia
    de Torres, Ines
    Maldonado, Xavier
    Morote, Juan
    Carles, Joan
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [46] Assessing the Relationship between Thrombosis and Immune-Related Adverse Events in Patients with Lung Cancer Treated with Immune Checkpoint Inhibitors
    Isaza, Daniela Arango
    O'Loughlin, Lauren
    Patell, Rushad
    Viray, Hollis
    Neuberg, Donna S.
    Dodge, Laura E.
    Rangachari, Deepa
    Asnani, Aarti
    Zwicker, Jeffrey, I
    Costa, Daniel
    BLOOD, 2022, 140 : 11372 - 11373
  • [47] The association between albumin-globulin ratio (AGR) and survival in patients treated with immune checkpoint inhibitors
    Guven, Deniz Can
    Aktepe, Oktay Halit
    Aksun, Melek Seren
    Sahin, Taha Koray
    Kavgaci, Gozde
    Ucgul, Enes
    Cakir, Ibrahim Yahya
    Yildirim, Hasan Cagri
    Guner, Gurkan
    Akin, Serkan
    Kertmen, Neyran
    Dizdar, Omer
    Aksoy, Sercan
    Erman, Mustafa
    Yalcin, Suayib
    Kilickap, Saadettin
    CANCER BIOMARKERS, 2022, 34 (02) : 189 - 199
  • [48] The association between albumin-globulin ratio (AGR) and survival in patients treated with immune checkpoint inhibitors
    Guven, D. C.
    Aktepe, O. H.
    Aksun, M. S.
    Sahin, T. K.
    Kavgaci, G.
    Ucgul, E.
    Cakir, I. Y.
    Yildirim, H. C.
    Guner, G.
    Akin, S.
    Kertmen, N.
    Dizdar, O.
    Aksoy, S.
    Erman, M.
    Yalcin, S.
    Kilickap, S.
    ANNALS OF ONCOLOGY, 2021, 32 : S1388 - S1388
  • [49] Eosinophil Count as Predictive Biomarker of Immune-Related Adverse Events (irAEs) in Immune Checkpoint Inhibitors (ICIs) Therapies in Oncological Patients
    Giommoni, Elisa
    Giorgione, Roberta
    Paderi, Agnese
    Pellegrini, Elisa
    Gambale, Elisabetta
    Marini, Andrea
    Antonuzzo, Andrea
    Marconcini, Riccardo
    Roviello, Giandomenico
    Matucci-Cerinic, Marco
    Capaccioli, David
    Pillozzi, Serena
    Antonuzzo, Lorenzo
    IMMUNO, 2021, 1 (03): : 253 - 263
  • [50] Association of biomarkers and outcomes in patients (pts) with metastatic urothelial carcinoma (mUC) treated with immune checkpoint inhibitors (ICIs).
    Reyes, Kevin R.
    Zhang, Li
    Zhu, Xiaolin
    Jindal, Tanya
    Deshmukh, Prianka
    de Kouchkovsky, Ivan
    Kumar, Vipul
    Maldonado, Edward
    Kwon, Daniel H.
    Chan, Emily
    Porten, Sima P.
    Borno, Hala
    Bose, Rohit
    Desai, Arpita
    Aggarwal, Rahul Raj
    Small, Eric Jay
    Fong, Lawrence
    Chou, Jonathan
    Friedlander, Terence W.
    Koshkin, Vadim S.
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41
12345